[go: up one dir, main page]

NO962547L - Paroxetintabletter og fremgangsmåte for å fremstille dem - Google Patents

Paroxetintabletter og fremgangsmåte for å fremstille dem

Info

Publication number
NO962547L
NO962547L NO962547A NO962547A NO962547L NO 962547 L NO962547 L NO 962547L NO 962547 A NO962547 A NO 962547A NO 962547 A NO962547 A NO 962547A NO 962547 L NO962547 L NO 962547L
Authority
NO
Norway
Prior art keywords
preparing
methods
paroxetine tablets
paroxetine
tablets
Prior art date
Application number
NO962547A
Other languages
English (en)
Other versions
NO307366B1 (no
NO962547D0 (no
Inventor
Ram Dutta Pathak
David Georg Doughty
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10746644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO962547(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO962547D0 publication Critical patent/NO962547D0/no
Publication of NO962547L publication Critical patent/NO962547L/no
Publication of NO307366B1 publication Critical patent/NO307366B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO962547A 1993-12-15 1996-06-14 Fremgangsmåte for fremstilling av tabletter inneholdende paroxetin og tablettformulering fremstilt ved fremgangsmåten NO307366B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939325644A GB9325644D0 (en) 1993-12-15 1993-12-15 Novel formulation
PCT/EP1994/004164 WO1995016448A1 (en) 1993-12-15 1994-12-14 Paroxetine tablets and process to prepare them

Publications (3)

Publication Number Publication Date
NO962547D0 NO962547D0 (no) 1996-06-14
NO962547L true NO962547L (no) 1996-06-14
NO307366B1 NO307366B1 (no) 2000-03-27

Family

ID=10746644

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962547A NO307366B1 (no) 1993-12-15 1996-06-14 Fremgangsmåte for fremstilling av tabletter inneholdende paroxetin og tablettformulering fremstilt ved fremgangsmåten

Country Status (36)

Country Link
US (1) US6113944A (no)
EP (1) EP0734260B2 (no)
JP (1) JP3037757B2 (no)
KR (1) KR100367796B1 (no)
CN (1) CN1071116C (no)
AP (1) AP540A (no)
AT (1) ATE180973T1 (no)
AU (1) AU697982B2 (no)
BG (1) BG62755B1 (no)
BR (1) BR9408219A (no)
CA (4) CA2214575C (no)
CZ (1) CZ287891B6 (no)
DE (1) DE69419033T2 (no)
DK (1) DK0734260T4 (no)
DZ (1) DZ1835A1 (no)
ES (1) ES2132610T5 (no)
FI (1) FI962445A (no)
GB (1) GB9325644D0 (no)
GR (1) GR3031047T3 (no)
HK (1) HK1012285A1 (no)
HU (1) HUT75880A (no)
IL (1) IL111978A (no)
MA (1) MA23395A1 (no)
MY (1) MY112123A (no)
NO (1) NO307366B1 (no)
NZ (1) NZ277790A (no)
OA (1) OA10297A (no)
PL (1) PL314980A1 (no)
RO (1) RO115413B1 (no)
RU (1) RU2146141C1 (no)
SA (1) SA94150373B1 (no)
SI (1) SI0734260T2 (no)
SK (1) SK282620B6 (no)
UA (1) UA42745C2 (no)
WO (1) WO1995016448A1 (no)
ZA (1) ZA949900B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US6638948B1 (en) * 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
ATE200781T1 (de) 1997-06-10 2001-05-15 Synthon Bv 4-phenylpiperidin-derivate
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
NZ523902A (en) * 2000-08-28 2004-05-28 Synthon Bv Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
AR034898A1 (es) 2001-07-31 2004-03-24 Lundbeck & Co As H Composicion cristalina que contiene escitalopram
HUP0401895A2 (hu) * 2001-10-22 2004-12-28 Synthon B.V. Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
CA2471715A1 (en) * 2001-12-28 2003-07-17 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
US20080032959A1 (en) * 2004-06-23 2008-02-07 Alves Stephen E Estrogen Receptor Modulators
US20060063737A1 (en) * 2004-08-18 2006-03-23 Holmdahl Lisa K Liquid paroxetine compositions
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
AU2006315684A1 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN109771381B (zh) * 2017-11-13 2021-02-19 北京福元医药股份有限公司 一种帕罗西汀药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116401A (no) * 1974-03-04 1975-09-11
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223334B1 (en) * 1985-08-10 1991-07-10 Beecham Group Plc Process for the preparation of aryl-piperidine carbinols
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
EP0558679A1 (en) * 1990-11-24 1993-09-08 BEECHAM GROUP plc Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
FI962445A0 (fi) 1996-06-12
CA2274387A1 (en) 1995-06-22
SA94150373A (ar) 2005-12-03
AU1314595A (en) 1995-07-03
NO307366B1 (no) 2000-03-27
BR9408219A (pt) 1997-08-26
GR3031047T3 (en) 1999-12-31
CN1071116C (zh) 2001-09-19
DE69419033T2 (de) 1999-11-25
CN1137236A (zh) 1996-12-04
ZA949900B (en) 1995-10-10
GB9325644D0 (en) 1994-02-16
RO115413B1 (ro) 2000-02-28
CA2214575C (en) 1999-12-07
HU9601665D0 (en) 1996-08-28
CA2178637C (en) 1997-12-23
KR100367796B1 (ko) 2003-07-22
CZ287891B6 (cs) 2001-03-14
IL111978A0 (en) 1995-03-15
IL111978A (en) 2000-07-16
ES2132610T5 (es) 2008-12-16
CA2214575A1 (en) 1995-06-22
AU697982B2 (en) 1998-10-22
EP0734260B2 (en) 2008-07-09
DK0734260T3 (da) 1999-11-15
MY112123A (en) 2001-04-30
JPH09506602A (ja) 1997-06-30
NZ277790A (en) 1998-02-26
CZ176396A3 (en) 1996-09-11
DE69419033D1 (de) 1999-07-15
DK0734260T4 (da) 2008-09-29
AP540A (en) 1996-09-20
FI962445A (fi) 1996-06-12
SI0734260T1 (en) 1999-08-31
JP3037757B2 (ja) 2000-05-08
SI0734260T2 (sl) 2008-12-31
OA10297A (en) 1997-10-07
SK75696A3 (en) 1996-11-06
BG100648A (bg) 1997-02-28
CA2274389A1 (en) 1995-06-22
CA2178637A1 (en) 1995-06-22
ATE180973T1 (de) 1999-06-15
UA42745C2 (uk) 2001-11-15
RU2146141C1 (ru) 2000-03-10
MA23395A1 (fr) 1995-07-01
HUT75880A (en) 1997-05-28
EP0734260B1 (en) 1999-06-09
EP0734260A1 (en) 1996-10-02
US6113944A (en) 2000-09-05
PL314980A1 (en) 1996-09-30
SK282620B6 (sk) 2002-10-08
BG62755B1 (bg) 2000-07-31
NO962547D0 (no) 1996-06-14
AP9400704A0 (en) 1995-01-31
HK1012285A1 (en) 1999-07-30
SA94150373B1 (ar) 2006-05-27
CA2274389C (en) 2004-09-14
DZ1835A1 (fr) 2002-02-17
WO1995016448A1 (en) 1995-06-22
ES2132610T3 (es) 1999-08-16

Similar Documents

Publication Publication Date Title
NO962547D0 (no) Paroxetintabletter og fremgangsmåte for å fremstille dem
DK194589D0 (da) Partikelformede vaskemidler og fremgangsmaade til fremstilling deraf
NO942193D0 (no) Metallocener og fremgangsmåte til deres fremstilling og bruk
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
NO961156D0 (no) 3-(5-tetrazolyl-benzyl) amino-piperidin-derivater og antagonister for tachykiner
NO931326D0 (no) Komposittprodukt og fremgangsmaate til fremstilling derav
NO940825D0 (no) 2-Debenzoyl-2-acyltaxolderivater og fremgangsmåter ved fremstilling derav
NZ238884A (en) Piperidine, tetrahydropyridine and pyrrolidine derivatives and
NO943763D0 (no) 4-arylamino-benzopyraner og beslektede forbindelser
NO932915D0 (no) Mikroporoest krystallinsk silikoaluminofosfat og fremgangsmaate for fremstilling av dette
IT8947953A0 (it) Compressa di cloridrato di rainitidina e procedimento per produrla
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
NO952205D0 (no) Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter
DK0735042T3 (da) Maltitolsammensætning og fremgangsmåde til fremstilling deraf
NO172472C (no) For og fremgangsmaate til fremstilling derav
NO941517L (no) 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse
NO954763D0 (no) Piperidinderivater, deres fremstilling og anvendelse
GB9414953D0 (en) Hydraulically set packer
NO943826D0 (no) Heteroarylpiperidiner, fremgangsmåte for fremstilling og farmasöytiske blandinger hvor de er tilstede
ZA947291B (en) Piperidine derivatives
SI0853619T1 (en) Disubstituted piperidine derivatives
NO951033D0 (no) Smeltebearbeidbar blokk-kopolyesterimid og fremgangsmåte for fremstilling derav
NO923260D0 (no) Antitumor-kedarcidin-kromoforkompleks og fremgangsmaate til fremstilling derav
NO933006D0 (no) Pynt og feste for haarender
KR940026066U (ko) 요동침대

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees